These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36499038)

  • 21. Impact of seizure activity on free extracellular phenytoin concentrations in amygdala-kindled rats.
    Potschka H; Baltes S; Fedrowitz M; Löscher W
    Neuropharmacology; 2011; 61(5-6):909-17. PubMed ID: 21736886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.
    Jourquin J; Tremblay E; Décanis N; Charton G; Hanessian S; Chollet AM; Le Diguardher T; Khrestchatisky M; Rivera S
    Eur J Neurosci; 2003 Sep; 18(6):1507-17. PubMed ID: 14511330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment.
    Avolio C; Filippi M; Tortorella C; Rocca MA; Ruggieri M; Agosta F; Tomassini V; Pozzilli C; Stecchi S; Giaquinto P; Livrea P; Trojano M
    Mult Scler; 2005 Aug; 11(4):441-6. PubMed ID: 16042227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal profile of matrix metalloproteinases and their inhibitors in a human endothelial cell culture model of cerebral ischemia.
    Reuter B; Rodemer C; Grudzenski S; Couraud PO; Weksler B; Romero IA; Meairs S; Bugert P; Hennerici MG; Fatar M
    Cerebrovasc Dis; 2013; 35(6):514-20. PubMed ID: 23817219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in human herpesvirus-6-infected infants with or without febrile seizures.
    Kittaka S; Hasegawa S; Ito Y; Ohbuchi N; Suzuki E; Kawano S; Aoki Y; Nakatsuka K; Kudo K; Wakiguchi H; Kajimoto M; Matsushige T; Ichiyama T
    J Infect Chemother; 2014 Nov; 20(11):716-21. PubMed ID: 25156011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The disruption of blood-brain barrier induced by long-term arsenic exposure is associated with the increase of MMP-9 and MMP-2: The characteristics are similar to those caused by senescence.
    Lv M; Ma X; Zhang K; Zhang M; Ji Y; Cheng L; Shao X; Guan Z; Cui J; Gao Y; Liu Y; Yang Y; Liu X
    Chem Biol Interact; 2023 Nov; 385():110743. PubMed ID: 37802410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
    Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
    PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report.
    Waszczykowska A; Podgórski M; Waszczykowski M; Gerlicz-Kowalczuk Z; Jurowski P
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson's Disease Mouse Model.
    Ruan Z; Zhang D; Huang R; Sun W; Hou L; Zhao J; Wang Q
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis.
    Palus M; Zampachová E; Elsterová J; Růžek D
    J Infect; 2014 Feb; 68(2):165-9. PubMed ID: 24091083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-brain barrier dysfunction significantly correlates with serum matrix metalloproteinase-7 (MMP-7) following traumatic brain injury.
    Nichols P; Urriola J; Miller S; Bjorkman T; Mahady K; Vegh V; Nasrallah F; Winter C
    Neuroimage Clin; 2021; 31():102741. PubMed ID: 34225019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase imbalance in inguinal hernia formation.
    Antoniou GA; Tentes IK; Antoniou SA; Simopoulos C; Lazarides MK
    J Invest Surg; 2011; 24(4):145-50. PubMed ID: 21675849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epilepsy and the blood-brain barrier.
    Cornford EM; Oldendorf WH
    Adv Neurol; 1986; 44():787-812. PubMed ID: 3085437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MMP-2/TIMP-2 System in Alzheimer Disease.
    Wang H; Huang L; Wu L; Lan J; Feng X; Li P; Peng Y
    CNS Neurol Disord Drug Targets; 2020; 19(6):402-416. PubMed ID: 32787764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1.
    Peng WH; Tien YC; Huang CY; Huang TH; Liao JC; Kuo CL; Lin YC
    J Ethnopharmacol; 2010 Feb; 127(3):606-13. PubMed ID: 20035854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of MMP-9 levels in the serum of patients with epilepsy.
    Wang Q; Lin Z; Yao C; Liu J; Chen J; Diao L
    Front Neurosci; 2024; 18():1296876. PubMed ID: 38449733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.
    Barr TL; Latour LL; Lee KY; Schaewe TJ; Luby M; Chang GS; El-Zammar Z; Alam S; Hallenbeck JM; Kidwell CS; Warach S
    Stroke; 2010 Mar; 41(3):e123-8. PubMed ID: 20035078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol attenuates the blood-brain barrier dysfunction by regulation of the MMP-9/TIMP-1 balance after cerebral ischemia reperfusion in rats.
    Wei H; Wang S; Zhen L; Yang Q; Wu Z; Lei X; Lv J; Xiong L; Xue R
    J Mol Neurosci; 2015 Apr; 55(4):872-9. PubMed ID: 25330860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epilepsy and Alterations of the Blood-Brain Barrier: Cause or Consequence of Epileptic Seizures or Both?
    Löscher W
    Handb Exp Pharmacol; 2022; 273():331-350. PubMed ID: 33136189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.